Sonder Capital — 2016 Investments
1 investments dated 2016 · listed companies and verified rows first · show all
RefleXion Medical develops SCINTIX autonomous radiotherapy, an external beam theranostic oncology platform that uses biological signals from radiopharmaceutical-labeled cancer cells to deliver real-time, motion-managed radiation to lung and bone tumors from primary or metastatic disease.
BiotechHealthtechMedical DevicesHayward, US
Samuel Mazin(Executive Officer, Director)inAkshay Nanduri(Executive Officer, Director)in
BoardJay Watkins(Director)in
Board seatFred Moll· per SEC Form D
Co-investorsAscension VenturesCatalio Capital Management, LPPfizer Venture InvestmentsSofinnova PartnersVenrock
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






